← Back to guidelines
Dermatology9 papers

Transient neonatal epidermolysis bullosa acquisita

Last edited: 4/10/2026

Overview

Transient neonatal epidermolysis bullosa acquisita (TNEA) is a rare, acquired blistering skin disease that presents in newborns 1. It is characterized by the formation of blisters on the skin shortly after birth 1.

Diagnosis

  • Diagnosis is based on clinical presentation and may be supported by specialized testing 1.
  • Management

  • Management is patient-specific and involves a multidisciplinary team approach 1.
  • Key areas of management include medical monitoring, wound care, pain management, feeding, and nutrition 1.
  • Parental psychosocial support is an important component of care 1.
  • Discharge planning and education for EB are crucial 1.
  • Key Recommendations

  • Neonatal care for epidermolysis bullosa should be based on evidence, clinical expertise, and trial and error, with collaboration between the EB specialist team, parents/carers, and patient, tailored to the neonate's individual presentation and EB type 1. (Evidence: Expert opinion)
  • A multidisciplinary team approach is essential to provide a patient-specific holistic care model that incorporates the needs and wishes of parents and carers 1. (Evidence: Expert opinion)
  • Early intervention based on research and clinical practice is needed to establish a foundation of knowledge to guide practitioners and improve standards of care for those newly diagnosed with EB 1. (Evidence: Expert opinion)
  • References

    1 Saad R, Duipmans J, Yerlett N, Plevey K, McCuaig C, Woolfe W et al.. Neonatal epidermolysis bullosa: a clinical practice guideline. The British journal of dermatology 2024. link

    Original source

    1. [1]
      Neonatal epidermolysis bullosa: a clinical practice guideline.Saad R, Duipmans J, Yerlett N, Plevey K, McCuaig C, Woolfe W et al. The British journal of dermatology (2024)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG